IntroductIon Biliary and pancreatic diseases, especially choledocholithiasis and neoplastic diseases, are commonly seen in elderly patients. Endoscopic retrograde cholangiopancreatography (ERCP) is a diagnostic and therapeutic procedure performed more and more frequently also in elderly patients.
IntroductIon
Recently there has been a con tinuous increase observed in the number of ad missions to hospital of patients advanced in age, especially >80 years of age. 1,2 A risk of bile duct diseases, including complicated cholelithiasis and malignant diseases, increases in the ageing popu lation.
3,4 One of the procedures used in diagnos tic evaluation and particularly therapy of biliary tract diseases is endoscopic retrograde cholang iopancreatography (ERCP). Currently, ERCP is mainly used to remove stones from bile ducts or to implant stents into the common bile duct and/or the main pancreatic duct. 5 This procedure carries the risk of fatal compli cations such as acute pancreatitis, gastrointesti nal hemo rrhage, perforation and allergy to con trast media or drugs administered during anes thesia. These complications may be particularly harmful in elderly patients, who more often have concomitant diseases. Only a few studies assess ing indications for and safety of ERCP in patients aged >80 years are available.
The aim of this study was to assess the frequen cy and safety of ERCP in elderly patients >80 years of age.
orIGInAL ArtIcLE
Assessment of frequency and safety of endoscopic retrograde cholangiopancreatography in patients over 80 years of age Choledocholithiasis was the main cause for admission to hospital in both groups of patients, namely the younger ones and those >80 years of age (tAbLE 2). Another admission causes repre sented bile duct strictures, pancreatic and ampulla of Vater tumors and hepatic hilus tumors. There was also no difference in the incidence of these diseases between the groups. In turn, chronic pan creatitis was diagnosed only in the patients ≤80 years. It is known that this disease affects main ly men, usually in the 4th or 5th decade of life. The mean age of participants of the current study hospitalized for chronic pancreatitis and under went ERCP was 47.3 years (16-60 years) .
The analysis of laboratory test results did not show any statistically significant differences be tween the two groups, both before ERCP and 24 hours after it. The comparison of laboratory test results is presented in tAbLE 3.
Complications were observed in 48 (5.8%) out of 821 patients, including 44 subjects aged <80 (6.1%) and 4 >80 years (4.2%; p >0.05). The most common complication was acute pancreatitis that occurred in 34 patients. It was observed in 32 subjects ≤80 years of age (4.4%) and in 2 old er individuals (2.1%, p >0.05). The occurrence of acute pancreatitis was associated with pro longed hospital stay in both younger and older (>80 years of age) patient groups up to 7.2 and 8.5 days, respectively. None of the patients re quired surgery.
Another complication, gastrointestinal hemo rrhage, occurred in 12 patients, including 10 (1.4%) ≤80 years of age and 2 (2.1%) >80 years of age. In 6 subjects (4 ≤80 years, and 2 >80 years) there was a need for red blood cell mass transfu sion (2-4 units). The time of hospital stay in pa tients with bleeding was 6.2 days for the young er subjects, and 6.5 days for those >80 years of age, which was not a significant difference. In all patients ab dominal ultrasonography had been performed ear lier, 388 patients (47.3%) had also had computed tomography done, and 53 (6.5%) magnetic reso nance cholangiopancreatography. Age, sex, indi cations for ERCP, its course and complication rate, and the mean hospital stay time were assessed in patients < and > 80 years of age. The results of laboratory tests were compared before ERCP and, if available, 24 hours after the procedure, and in case of complications also surgical records were analyzed. All ERCP procedures were performed by 2 experienced endoscopists (B. W. i M. P.).
According to the approved criteria, acute postERCP pancreatitis was diagnosed when clin ical symptoms occurred simultaneously, main ly pain in the epigastric and periumbilical re gion, and over a 3fold increase in the serum amylase level that persisted for >24 hours after the procedure.
PostERCP hemo rrhage was diagnosed on the basis of clinical symptoms and a decrease in the hemo globin level of at least 2 g/dl. Cases of bleeding that were only present during ERCP and could be followed without any clinical conse quences, were not regarded as procedural compli cations. Perforation was suspected on the grounds of contrast medium leakage outside the bile and pancreatic ducts during ERCP. 6,7
Data on 2 groups were compared using Stu dent's ttest or the χ 2 test. The results were presented as mean ± standard deviation, and a p <0.05 was considered significant. 15 Therefore, in el derly patients this complication is usually rare ly reported. The risk of acute pancreatitis after ERCP also increases following administration of large amounts of contrast medium, multiple cannulation attempts and manipulations in pan creatic ducts. 14, 15 Another complication, gastrointestinal hemo rrhage, occurs most often after ERCP with endo scopic sphincterotomy, and its incidence has been estimated at 1-5% up to 10-30% of patients.
14,15
The results of this study demonstrated that bleed ing occurred in 1.5% of all patients who under went ERCP in the years 2005-2007. Its incidence in elderly subjects was not higher, which is in line with results of other studies.
9-11
Perforation of digestive tract is a rare but se vere complication of ERCP. Its occurrence depends on the anatomy of distal segment of the common bile duct and the length of major duodenal papil la cut. The factors predisposing to this complica tion involve Billroth II gastrectomy, endoscopic sphincterotomy, intramural injection of contrast medium and dilation of bile duct stricture.
1,16
In the study by Enns et al. the patient's advanced age was also recognized an independent risk fac tor for perforation, which occurred in patients about 10 years older than the rest. 16 In contrast, the analysis of ERCP performed in the Depart ment showed that perforation affected only 2 pa tients who belonged to the younger group (≤80 years). In most studies conservative therapy was sufficient and patients, like in the present study, did not require surgical inter vention. 7, 16 Compar ative analysis of complication incidence showed that ERCP is a safe procedure regardless of the pa tient age.
9-11,17-19 Another conclusion from this study is that the mean time of hospital stay was similar in both groups, being 4.8 days for patients On the other hand, perforation was suspected at 2 ERCP procedures (0.3%) in the group ≤80 years of age. These patients underwent surgical consultation and one of them was transferred to the Department of General and Transplant Sur gery of the Medical University of Łódź. Finally, after conservative treatment both patients were discharged from hospital without surgery.
There was no allergic reactions to contrast me dia or anesthesia complications in available med ical records. There was no fatal postERCP com plications. The mean hospital stay period was 4.8 days for patients ≤80 years of age and 5.7 days for those >80 years (p >0.05; tAbLE 4). dIscussIon The percentage of patients >80 years of age who underwent ERCP in the De partment of Gastrointestinal Diseases is similar to that reported by other authors. [8] [9] [10] [11] In the cur rent analysis ERCP was mainly performed because of choledocholithiasis in both younger and >80 years old patients. Likewise, in the study by Köklü et al. choledocholithiasis was diagnosed in 52% of patients by the age of 69, and in 50.5% of older individuals.
9 In other studies choledocholithiasis was also the most common indication for ERCP in patients >80 years of age. 10, 11 In the present study a statistically significant difference was ob served only for the incidence of ERCP performed because of chronic pancreatitis. All ERCP proce dures performed in the Department for this rea son concerned patients <80 years, mean age 47.3 years (16-60 years) . This age corresponds with the peak incidence of chronic pancreatitis, es pecially of alcoholic etiology. Over the age of 80 chronic pancreatitis is diagnosed significantly less frequently. 12 The most common postERCP complication is acute pancreatitis. Its incidence is 1.3% to even 30% of cases. [13] [14] [15] In this study acute pancreati tis affected 4.4% of younger patients and 2.1% of subjects >80, with no statistically significant ≤80, and 5.7 days for those >80 years of age. Like wise, the study by Katsinelos et al. conducted in 2 age groups, 70-89 years and >90 years old, did not show any differences between efficacy of ERCP and its complication rate that allows re garding this procedure as safe. 17 It should be emphasized that the success of ERCP is conditioned by its performance by an experienced endoscopist, anesthesia by an experienced anesthetist, and by avoid ing longer procedure by multiple cannulation attempts and pancreatic duct manipulations. 20 To sum up, the authors believe that choice of the most favorable management for an in dividual patient, together with the appropriate preparation and monitoring during the proce dure, ensure safety also for the patients >80 years of age. 
